Praxis Precision Medicines Inc (PRAX) USD0.0001

Sell:$35.04Buy:$35.17$3.50 (8.98%)

NASDAQ:0.87%
Market closed | Prices delayed by at least 15 minutes
Sell:$35.04
Buy:$35.17
Change:$3.50 (8.98%)
Market closed | Prices delayed by at least 15 minutes
Sell:$35.04
Buy:$35.17
Change:$3.50 (8.98%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The Company is applying genetic insights to the discovery and development of therapies for neurological disorders through two platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small-molecule platform, which utilizes deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies, and Solidus, an antisense oligonucleotide platform, is an efficient, targeted precision medicine discovery and development engine anchored on a proprietary, computational methodology. The Company’s product candidates include ulixacaltamide, vormatrigine, relutrigine, PRAX-080, and others.

Key people

Marcio Souza
President, Chief Executive Officer, Director
Timothy E. Kelly
Chief Financial Officer
Alex Nemiroff
General Counsel, Corporate Secretary
Dean Mitchell
Independent Chairman of the Board
Jeffrey A. Chodakewitz
Independent Director
Merit Cudkowicz
Independent Director
Jill Desimone
Independent Director
Gregory Norden
Independent Director
Click to see more

Key facts

  • EPIC
    PRAX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US74006W2070
  • Market cap
    $793.58m
  • Employees
    116
  • Shares in issue
    20.37m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.